1Gamelin E,Gamelin L,Bossi L,et al.Clinical aspects and molecular basis of oxaliplatin neurotoxicity:current management and development of preventive measures[J].Semin Oncol,2002,29(1):21-33.
2Stein A,Arnold D.Oxaliplatin:a review of approved uses[J].Expert Opin Pharmacother,2012,13(1):125-137.
3Raymond E,Chaney SG,Taamma A,et al.Oxaliplatin:A review of preclinical and clinical studies[J].Ann Oncol,1998,9(10):1053-1071.
4Bullinger KL,Nardelli P,Wang Q,et al.Oxaliplatin neurotoxicity of sensory transduction in rat proprioceptors[J].J Neurophysiol,2011,106(2):704-709.
5Lersch C,Schmelz R,Eckel F,et al.Prevention of oxaliplatininduced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer[J].Clin Colorectal Cancer,2002,2(1):54-58.
6S von Delius,F Eckel,S Wagenpfeil,et al.Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer:final results of a randomised,controlled,multicenter phase II study[J].Invest N Drugs,2007,25(2):173-180.
7Chong MS,Smith TE,Hanna M.Anticonvulsants for the management of pain[J].Euor Pain J,2002,21(1):5-11.
8Gamelin L,Boisdron CM,Delva R,et al.prevention of oxaliplatin related neurotoxicity by alcium and magnesium infusions a retrospective study of 161 patients receiving oxaliplatin combined with5-fluorouracil and leucovorin for advanced colorectal cancer[J].Clin Cancer Res,2004,10(1):4055-4061.
9Kanai M,Yoshioka A,Tanaka S,et al.Associations between glutathione S-transferase pille105Valand glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-inducedneuropathy[J].Cancer Epidemiol,2010,34(2):189-193.
